好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2020 Annual Meeting | P4 - Poster Session 4

Sunday 04/26/20
05:30 PM - 06:30 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Neuro-ophthalmology/Neuro-otology, Aging, Dementia, and Behavioral Neurology, Autoimmune Neurology, Cerebrovascular Disease and Interventional Neurology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Headache, Movement Disorders, Multiple Sclerosis, Neuromuscular and Clinical Neurophysiology (EMG), Neuro-oncology
0.00 credit
Event Timeline
05:30 PM - 06:30 PM Abstract 9-001 - In depth analysis of B cells in multiple sclerosis patients after long-term treatment with Alemtuzumab
05:30 PM - 06:30 PM Abstract 9-002 - Finding New Targets for the Understanding and Treatment of Multiple Sclerosis: Modeling Multiple Sclerosis through Disease-Specific Neural Stem Cells
Paul M. Elsbernd, MD
05:30 PM - 06:30 PM Abstract 9-003 - Immunoglobulins Modulated Oxidative Stress and Cytokines Expression in Human Microglial Cells Induced by Ketone Bodies
Nizar Souayah, MD, FAAN
05:30 PM - 06:30 PM Abstract 9-004 - Expression Profiles of Novel Noncoding RNAs in the CSF and Blood Samples of Multiple Sclerosis Patients
Anna Iacoangeli, PhD
05:30 PM - 06:30 PM Abstract 9-005 - Single Cell Analysis of MS CSF B-Cells Show Significant Differences in Expansion Patterns and Gene Family Usage Between MS Subtypes
05:30 PM - 06:30 PM Abstract 9-006 - Ingested ACTH Blocks Th17 Production by Inhibiting GALT IL-6
Staley A. Brod, MD
05:30 PM - 06:30 PM Abstract 9-007 - Demyelinated White Matter Exhibits Upregulated DNA Damage Response and Cellular Senescence in Progressive Multiple Sclerosis
Richard S. Nicholas, FRCP
05:30 PM - 06:30 PM Abstract 9-008 - The Role of Metabotropic Glutamate Receptors in Cerebellar Dysfunction in Multiple Sclerosis
Julia Granato
05:30 PM - 06:30 PM Abstract 9-009 - Bone health, fracture risk, and Multiple Sclerosis: a UK Biobank study
Sara Leddy, MBBS
05:30 PM - 06:30 PM Abstract 9-010 - Clinical profile of African-American and Caucasian patients with Multiple Sclerosis
Maria Petracca, PhD
05:30 PM - 06:30 PM Abstract 9-011 - Comparison of the proportions of Secondary Progressive Multiple Sclerosis between three registries within the SPMS Research Collaboration Network
05:30 PM - 06:30 PM Abstract 9-012 - Obesity is associated with Optic Neuritis severity in Male patients with Multiple Sclerosis
Duong T. Chu, MD
05:30 PM - 06:30 PM Abstract 9-013 - Environmental exposures associated with Multiple Sclerosis: a UK Biobank study
05:30 PM - 06:30 PM Abstract 9-014 - Late Onset Multiple Sclerosis: an Epidemiologic Study from the First Brazilian MS Center
Keila Narimatsu, MD
05:30 PM - 06:30 PM Abstract 9-015 - A seasonal pattern of clinical activity remains in untreated MS patients in Montpellier and CLIMB cohort.
05:30 PM - 06:30 PM Abstract 9-016 - Epilepsy and multiple sclerosis: a comorbidity in Argentinian cohort patients without progressive forms
Guido D. Vazquez II, PhD
05:30 PM - 06:30 PM Abstract 9-017 - Tracking cognitive change in people with multiple sclerosis – 5 year follow up of the original Irish BICAMS validation cohort.
Maria Gaughan, MBBS
05:30 PM - 06:30 PM Abstract 9-018 - Decreasing RTX Doses are associated with Stable Disease in Patients with Multiple Sclerosis
Claudio Gobbi, MD
05:30 PM - 06:30 PM Abstract 9-019 - Increasing Trends of Cancer Diagnoses in People with Multiple Sclerosis
Claudio Gobbi, MD
05:30 PM - 06:30 PM Abstract 9-020 - Timing is Everything: Comorbid Conditions Diagnosed after Multiple Sclerosis have Greater Effect on Disability, Participation and Quality of Life Among Older People with Multiple Sclerosis
Megan C. Kirkland
05:30 PM - 06:30 PM Abstract 15-001 - Clinical and Immunological Investigation of Glial Fibrillar Acidic Protein Astrocytopathy in China—A Single Center Study of 11 Cases
Lei Liu, MD, PhD
05:30 PM - 06:30 PM Abstract 15-002 - Case of Concurrent Herpes simplex Encephalitis and Leucine-Rich Glioma Inactivated 1 Encephalitis
John Peters, MD
05:30 PM - 06:30 PM Abstract 15-003 - Concomitant Chorea, Head Tremor and Cerebellar Degeneration; a Rare Combination in a Case of CRMP-5 Encephalitis
Harsh Patel, MBBS
05:30 PM - 06:30 PM Abstract 15-004 - Profile Of Patients With Guillain- Barre Syndrome During Pregnancy In A Tertiary Care Hospital In South India.
Namrata Jayaharan
05:30 PM - 06:30 PM Abstract 15-005 - Can Certain Baseline Characteristics in Patients with Stiff Person Syndrome (SPS) Predict Disease Burden and Functional Outcomes?
Loulwah Mukharesh, MD
05:30 PM - 06:30 PM Abstract 15-006 - Determination of sensitivity and specificity of live clustered cell based acethylcholine antibody assay in a well characterized cohort of adult myasthenia gravis patients
Jeff Guptill, MD, FAAN
05:30 PM - 06:30 PM Abstract 15-007 - Validation of live clustered cell based acethylcholine antibody assay and utility in children with myasthenia gravis
Hans Frykman, MD, PhD, FRCPC
05:30 PM - 06:30 PM Abstract 15-008 - Validation of a Surface Plasmon Resonance Assay for the Diagnostic Detection and Characterization of Muscle-specific Kinase (MuSK) Antibodies in Myasthenia Gravis Patients
Hans Frykman, MD, PhD, FRCPC
05:30 PM - 06:30 PM Abstract 15-009 - Additional Analyses of the Phase 2 Efgartigimod Study in Myasthenia Gravis
James F. Howard, Jr., MD, FAAN
05:30 PM - 06:30 PM Abstract 15-010 - Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Sumit Verma, MD
05:30 PM - 06:30 PM Abstract 15-011 - Effect of Complement Inhibition on Lymphocytes in Treatment Refractory Myasthenia Gravis Patients
Jeff Guptill, MD, FAAN
05:30 PM - 06:30 PM Abstract 15-012 - B cell subsets and T follicular helper cells in myasthenia gravis thymus
05:30 PM - 06:30 PM Abstract 3-001 - CSF biomarkers in Parkinson patients with and without freezing of gait
Johnathan L. McKay, PhD
05:30 PM - 06:30 PM Abstract 3-002 - Cortical Responses to Balance Perturbation are Abnormal in Parkinson’s Disease
Aiden Payne, PhD
05:30 PM - 06:30 PM Abstract 3-003 - Exploring the Parkinson’s disease phenome in the UK Biobank population
Daniel Belete, MBChB
05:30 PM - 06:30 PM Abstract 3-004 - Inhibiting the Depalmitoylase APT1 Protects Against Alpha-synuclein Neurotoxicity: A Novel Target for Disease-modifying Therapy in Human Synucleinopathies
Gary Ho, MD, PhD
05:30 PM - 06:30 PM Abstract 3-005 - Neuroinflammation Genomic Markers in Genome-wide Association Study of Parkinson's Disease
Sun Ju Chung, MD, PhD, FAAN
05:30 PM - 06:30 PM Abstract 3-006 - Cortical High-Beta EEG Response to Dopaminergic Therapy in Parkinson’s Disease
05:30 PM - 06:30 PM Abstract 3-007 - Lower Vitamin B12 Level at Parkinson’s Disease Diagnosis is Associated with Higher Risk of Dementia in the Future
Stuart J. McCarter, MD
05:30 PM - 06:30 PM Abstract 3-008 - Low serum Uric Acid levels are related to dyskinesia and postural instability/gait difficulty in Parkinson's Disease
05:30 PM - 06:30 PM Abstract 3-009 - Abnormal intracortical facilitatory-inhibitory circuit interactions in patients with Parkinson’s disease
05:30 PM - 06:30 PM Abstract 3-010 - Antibody Synthesis in the CNS is Associated with Cognition in Parkinson’s disease
Marian Shahid
05:30 PM - 06:30 PM Abstract 3-013 - High Serum Cortisol levels are associated with fatigue and verbal fluency in Parkinson's Disease: preliminary results
05:30 PM - 06:30 PM Abstract 3-014 - GBA and ATP13A mutation and PD: clinical phenotype and pathogenic implications
Giulietta Riboldi, MD
05:30 PM - 06:30 PM Abstract 3-015 - An Inconsistency Investigated: Parkinson's Retrospective Autopsy Series and Clinicopathologic Correlation
Ali Eltatawy, MD
05:30 PM - 06:30 PM Abstract 3-016 - Brain Functional Plasticity of the Limbic Circuit in Parkinson’s Disease Patients with Freezing of Gait
Elisabetta Sarasso
05:30 PM - 06:30 PM Abstract 12-001 - EEG Patterns Predicting Poor Prognosis In Elderly Patients With Generalised Convulsive And Non-Convulsive Status Epilepticus
Devavrat H. Nene, MBBS, DM
05:30 PM - 06:30 PM Abstract 12-002 - Assessing the Value of Interhospital Transfer for Patients with Suspected Status Epilepticus (SE)
Ian Cossentino, BS
05:30 PM - 06:30 PM Abstract 12-003 - Marked Response to Lidocaine Plus MgSO4 Treatment in a New Onset Febrile Infection-Related Refectory Status Epilepticus
Helen B. Burks, MD
05:30 PM - 06:30 PM Abstract 12-004 - Pregabalin As Adjunctive Treatment For Symptomatic Cyclic Seizures In Neurocritically Ill Patients
Zachary M. Newcomer, DO
05:30 PM - 06:30 PM Abstract 12-005 - Patient and Caregiver Preference for Route of Administration of a Benzodiazepine for Control of Increased Seizure Activity in Stable Patients
Gary Slatko, MD
05:30 PM - 06:30 PM Abstract 12-006 - NORSE (New Onset Refractory Status Epilepticus) due to ANNA-2 associated paraneoplastic encephalitis
Carolina Cuello-Oderiz, MD
05:30 PM - 06:30 PM Abstract 12-007 - A case of isolated and prolonged aphasic status epilepticus
Chen Chen, MD
05:30 PM - 06:30 PM Abstract 12-008 - Cardiology Perspective on Seizure Related Bradyarrhythmias and SUDEP: A Survey Study
Mark Farrenburg, MD
05:30 PM - 06:30 PM Abstract 12-009 - Frequency and Types of Electrocardiogram Abnormalities Found During Electroencephalogram Recordings
Khalid I. El-Salem, MD, FAAN
05:30 PM - 06:30 PM Abstract 12-010 - Fixation off sensitivity and other Eye condition related epileptiform discharges, an institutional cohort
Smitha Chandran
05:30 PM - 06:30 PM Abstract 12-011 - Utility of Continuous Video EEG in patients with Cardiac Arrest
Ritika Suri, MD
05:30 PM - 06:30 PM Abstract 12-012 - Continuous EEG for Seizure Detection in Neonates after Cardiac Bypass without Deep Hypothermic Cardiac Arrest
Rebecca J. Levy, MD
05:30 PM - 06:30 PM Abstract 6-001 - Sleep Restriction Therapy for Drosophila Models of Neurodegenerative Disease
Samuel Belfer, MD, PhD
05:30 PM - 06:30 PM Abstract 6-002 - Comparison of Different Criteria for Refractory Myasthenia Gravis
05:30 PM - 06:30 PM Abstract 6-003 - Eponyms are here to stay: Usage in the literature and among current neurology trainees
05:30 PM - 06:30 PM Abstract 6-004 - NeuroBytes: A new rapid, high-yield, nationwide e-Learning platform for continuing professional development in neurology
Laura E. Lavette
05:30 PM - 06:30 PM Abstract 6-005 - Interactions Between Hippocampal Features and Sleep Spindle Architecture in Cognitively Normal Elderly
05:30 PM - 06:30 PM Abstract 6-006 - A Novel Epigenetic Factor Regulates Adult Mammalian Peripheral Nervous System Axon Regeneration
05:30 PM - 06:30 PM Abstract 6-007 - A Novel PCA-Based fMRI Noise Reducing Wishart Filter to Improve Diagnosis of Neurodegeneration
05:30 PM - 06:30 PM Abstract 7-001 - Effects of Lasmiditan on Cardiovascular Parameters in Healthy Subjects Receiving Oral Doses of Propranolol
05:30 PM - 06:30 PM Abstract 7-002 - The Aimovig “Wear-Off”: A Retrospective Case Series of Response to 14 day Dosing
Naveen George, DO
05:30 PM - 06:30 PM Abstract 7-003 - A Comparison of Efficacy, Tolerability and Safety in Subjects with Hemicrania Continua Responding to Indomethacin and Specialized Boswellia Serrata Extract
Eric J. Eross, DO
05:30 PM - 06:30 PM Abstract 7-004 - Effect of Dihydroergotamine Infusion Rate on Inpatient Headache Treatment Outcomes
Nina Y. Riggins, MD, FAAN
05:30 PM - 06:30 PM Abstract 7-005 - Pterygopalatine Fossa Blockade: a novel, narcotic-sparing Treatment for Headache in Patients with Aneurysmal Subarachnoid Hemorrhage
Katharina M. Busl, MD, MS, FAAN
05:30 PM - 06:30 PM Abstract 7-006 - Management of Childhood Migraine by Headache Specialist versus Non-Headache Specialists
Kelly Valentini
05:30 PM - 06:30 PM Abstract 7-007 - Post marketing experiences with erenumab (Aimovig) for the treatment of chronic migraine in a real-life clinical setting
Carolyn Zyloney, MD
05:30 PM - 06:30 PM Abstract 7-008 - Building a Case for Magnesium in Reversible Cerebral Vasoconstriction
Mallory N. Luckey, MD
05:30 PM - 06:30 PM Abstract 7-009 - Utility of “Migraine Cocktail” in the Pediatric Emergency Department
Ankita Ghosh, MD
05:30 PM - 06:30 PM Abstract 7-010 - Evaluation of Behavioral Insomnia Treatment in Shared Medical Visit Setting for Migraineurs with Comorbid Insomnia: Application of the RE-AIM Framework
05:30 PM - 06:30 PM Abstract 7-011 - A Pilot Randomized Controlled Study of a Smartphone Delivered Progressive Muscle Relaxation Intervention for Migraine in Primary Care
Mia T. Minen, MD, FAAN
05:30 PM - 06:30 PM Abstract 7-012 - Time Trends in Opiate use for Headaches after Aneursymal Subarachnoid Hemorrhage
Vyas Viswanathan, MD
05:30 PM - 06:30 PM Abstract 7-013 - Are People with Migraine Willing to Engage in Digitally Based Behavioral Therapies: A look at recruitment statistics for a mobile health study
Mia T. Minen, MD, FAAN
05:30 PM - 06:30 PM Abstract 1-001 - Extended Duration Plasmapharesis does not Improve Outcomes in Myasthenic Crisis
Lee E. Neilson, MD
05:30 PM - 06:30 PM Abstract 1-002 - Interactions Between Myasthenia Gravis and Pregnancy
Mohammed S. Alharbi, MD
05:30 PM - 06:30 PM Abstract 1-003 - Survey to assess variability in management of myasthenic crisis among neurologists
Neil Manering, MD
05:30 PM - 06:30 PM Abstract 1-004 - Positive Acetylcholine Receptor Antibody - A Subtle Sign of An Occult Endometrial Cancer
Abinayaa Purushothaman Ravichandran, MBBS
05:30 PM - 06:30 PM Abstract 1-005 - Anti-MuSK Antibody Positive Myasthenia Gravis Patient Demographics, Symptomatology, and Treatment Responsiveness in the University of Southern California Neuromuscular Clinic: A Retrospective Analysis
Victoria A. Cannon, MD
05:30 PM - 06:30 PM Abstract 1-006 - Validation of the Spanish Version of the 15-Item Myasthenia Gravis Quality of Life Scale (MG-QOL15)
Marcus Cimino, MD
05:30 PM - 06:30 PM Abstract 1-007 - Retrospective Analysis of Comorbidities Associated with Myasthenia Gravis
Brian Blankenship, MD
05:30 PM - 06:30 PM Abstract 1-008 - Effects of Medication Adjustment on Myasthenia Gravis Patients and Time to Readmission in an Academic Center
Connie G. Tang, MD
05:30 PM - 06:30 PM Abstract 1-009 - Autoimmune Myocarditis Associated to Seropositive Myasthenia Gravis
Sonia M. Caraballo-Cartagena, MD
05:30 PM - 06:30 PM Abstract 1-010 - Pseudomyasthenia Gravis: An uncommon and potentially hazardous mimicker of mitochondrial disease
Prompan Mingbunjerdsuk, MD
05:30 PM - 06:30 PM Abstract 1-011 - Refractory Myasthenia Responsiveness to Eculizumab in a Tertiary Care Setting in Challenging Cases
Uzma Usman, MD, FAAN
05:30 PM - 06:30 PM Abstract 1-012 - When My-“asthenia” is NOT due to Myasthenia Gravis
Richard A. Lewis, MD
05:30 PM - 06:30 PM Abstract 10-001 - Aberrant accumulation of BRCA1 in Alzheimer’s disease and other tauopathies.
Masataka Nakamura
05:30 PM - 06:30 PM Abstract 10-002 - Activation of mGluR1 enhances C1q-Dependent Microglial Phagocytosis of Glutamatergic Synapses in Alzheimer's Rodent Models
Sophia Wu, MD
05:30 PM - 06:30 PM Abstract 10-003 - Expression of VGF in T-lymphocytes is age dependant and increased in patients with Alzheimer’s disease
Eva Christina Meyer, MD
05:30 PM - 06:30 PM Abstract 10-004 - Increased Lamin A expression and heterochromatin changes in the hippocampus at early Alzheimer’s disease stages
Ildefonso Rodriguez-Leyva, MD, PhD, FAAN
05:30 PM - 06:30 PM Abstract 10-005 - Reduction of Astrocytic Glutamate Transporter Contributes to Amyloid-induced phagocytosis
Sophia Wu, MD
05:30 PM - 06:30 PM Abstract 10-006 - Galectin 3 binding protein suppresses Aß production by modulating ß-cleavage of amyloid precursor protein
05:30 PM - 06:30 PM Abstract 10-007 - A novel small molecule tyrosine kinase inhibitor (GUtinib) preferentially targets discoidin domain receptors and reduces toxic proteins in neurodegeneration
Alan Fowler
05:30 PM - 06:30 PM Abstract 10-008 - Prelimbic Cortex Inactivation Alters Prospective Reward Representation in Male Fischer 344 × Brown Norway F1 Hybrid Rats
Chase Labiste
05:30 PM - 06:30 PM Abstract 10-009 - FDG PET Illustrates Hypometabolism in a Mouse Model of Alpha-Synucleinopathy
05:30 PM - 06:30 PM Abstract 10-010 - Rab GTPase Proteins in Tauopathy
Nikolaus McFarland, MD, PhD, FAAN
05:30 PM - 06:30 PM Abstract 10-011 - The Effects of Stimulation of Innate Immunity with CpG-ODN in a Tauopathy Mouse Model, rTg4510
Jennifer L. Dobson, MD
05:30 PM - 06:30 PM Abstract 4-001 - National Institute of Neurological Disorders and Stroke (NINDS) Common Data Elements (CDEs): Updates to the Stroke V1.0 Recommendations
Katelyn E. Gay
05:30 PM - 06:30 PM Abstract 4-002 - An Exploratory Study to Investigate the Association between Short-term Exposure to Air-Pollution on the Occurrence of Ischemic or Hemorrhagic Stroke in a Case-crossover Design
05:30 PM - 06:30 PM Abstract 4-003 - Cost of Hospitalization for Stroke in a Low-Middle Income Country: Findings from a Public Tertiary Hospital in the Philippines
Jose Danilo B. Diestro, MD
05:30 PM - 06:30 PM Abstract 4-004 - Epidemiological profiling for stroke in Nepal: A need for establishing a stroke database in low income nations
05:30 PM - 06:30 PM Abstract 4-005 - Temporal Trends in Hemicraniectomy Utilization
Sai P. Polineni, MD
05:30 PM - 06:30 PM Abstract 4-006 - National Trends In Utilization And Outcomes Of Endovascular Treatment In Acute Ischemic Stroke Patients In Pre- And Post-stent Retriever Era In The United States
Saqib A. Chaudhry, MD
05:30 PM - 06:30 PM Abstract 4-007 - Real World Prevalence and Treatment of Large Vessel Occlusion Stroke
John H. Erdman III, MD
05:30 PM - 06:30 PM Abstract 4-008 - Characteristics of Stroke in the Young in a Diverse Urban County
Joseph Dardick
05:30 PM - 06:30 PM Abstract 4-009 - Epidemiology of Cerebral Ischemic Stroke in Southern Region in Saudi Arabia And Expected Role of Neurosurgery
05:30 PM - 06:30 PM Abstract 4-010 - Do Gender and Race/Ethnicity Affect the Timing to CT-Head in Acute Stroke Patients?
Sara Shapouran, MD
05:30 PM - 06:30 PM Abstract 4-011 - Delaying tPA Decision Impacts Overall Stroke Alert Efficiency: A Quality Improvement Initiative to Improve tPA Door to Needle Times
Daniel Cristancho, MD
05:30 PM - 06:30 PM Abstract 4-012 - Ongoing Quality Improvement for Acute Ischemic Stroke at Comprehensive Stroke Center
Shimeng Liu, MD, PhD
05:30 PM - 06:30 PM Abstract 4-013 - The E-ASPECTS Improves The Performance Of Emergencists In The Evaluation Of Early Signs Of Ischemia
05:30 PM - 06:30 PM Abstract 4-014 - An Interdisciplinary Intervention to Improve Time to Systemic Thrombolysis for Inpatient Acute Ischemic Strokes
Harn Shiue, PharmD
05:30 PM - 06:30 PM Abstract 4-015 - Points of In-Hospital Delays in Thrombolytic Therapy among Patients with Acute Ischemic Stroke: A Single Center 5-Year Retrospective Study
05:30 PM - 06:30 PM Abstract 4-016 - Identifying Predictors for Final Diagnosis of Ischemic Events in an Emergency Department Observation Unit
Arooshi Kumar, MD
05:30 PM - 06:30 PM Abstract 4-017 - Evolution of Decompressive Hemicraniectomy Practice at a Single Academic Institution: Inclusion of Elderly Patients
Amanda Opaskar, MD
05:30 PM - 06:30 PM Abstract 4-018 - Comparison of Existing and New Heparin Nomograms for the Treatment of Cerebrovascular Disease
Shadi V. Barbu, MD
05:30 PM - 06:30 PM Abstract 4-019 - Outcomes of Ischemic Stroke amongst patients on Long-term Current Use of Dual Anti-platelet Therapy Versus Aspirin Monotherapy.
Urvish K. Patel
05:30 PM - 06:30 PM Abstract 4-020 - Comparative effectiveness of dual antiplatelet therapy with aspirin and clopidogrel versus aspirin monotherapy in acute mild-to-moderate ischemic stroke according to the recurrent stroke risks: An analysis of 15000 patients from a nationwide, multicenter registry
Joontae Kim, MD, PhD
05:30 PM - 06:30 PM Abstract 4-021 - Loading dose of aspirin and clopidogrel prior to carotid artery stenting reduces cerebral ischemic events compared to the historic CREST trial.
Yahia M. Lodi, MD, FAAN
05:30 PM - 06:30 PM Abstract 13-001 - Intrathecal Methotrexate Induced Dorsal Column Syndrome
Christopher S. Nance, MD
05:30 PM - 06:30 PM Abstract 13-002 - Leptomeningeal Carcinomatosis- A case with a mismatch of clinical and radiological picture.
Varun Kumar Pala, MD
05:30 PM - 06:30 PM Abstract 13-003 - Paraneoplastic Opsoclonus-Myoclonus Syndrome and Prostate Cancer: First Reported Case
05:30 PM - 06:30 PM Abstract 13-004 - Initial and follow up imaging in paraneoplastic rhombencephalitis from Hodgkin’s lymphoma
Rebecca L. Hurst, MD
05:30 PM - 06:30 PM Abstract 13-005 - Persistent Aglycorrhachia in Leptomeningeal Carcinomatosis
Yongyao Kong, MBBS
05:30 PM - 06:30 PM Abstract 13-006 - Autoimmune disease-related primary CNS lymphoma: Review of literature and meta-analysis.
Leon D. Kaulen, MD
05:30 PM - 06:30 PM Abstract 13-007 - A Neurologists role in Gamma Knife: time for a paradigm shift?
Glen H. Stevens, DO, PhD, FAAN
05:30 PM - 06:30 PM Abstract 13-008 - Brainstem Anaplastic Astrocytoma, IDH-Mutant, WHO Grade III Presenting with Multiple Cranial Nerve Palsies and Diffuse Neuroaxis Leptomeningeal Involvement
Yasmin Aziz, MD
05:30 PM - 06:30 PM Abstract 13-009 - Initial Presentation of Papillary Craniopharyngioma with BRAF Mutation Treated with Adjuvant Chemotherapy
Mangala Gopal, MD
05:30 PM - 06:30 PM Abstract 13-010 - Treatment of Cisplatin Induced Neurotoxicity with High Dose Pyridoxine and Pyridostigmine
Nicole Thomason
05:30 PM - 06:30 PM Abstract 13-011 - Correlation of fiber tracts with speech outcome in brain glioma
Fereshteh N. Behdani, MD
05:30 PM - 06:30 PM Abstract 13-012 - Standardizing care of leptomeningeal carcinomatosis (LMC): Impact on survival and the role for advanced practitioners in developing Ommaya clinics
Erika Leese, PA
05:30 PM - 06:30 PM Abstract 13-013 - Neuroimaging Characteristics in Neoplastic Chronic Meningitis
John Herbst, DO
05:30 PM - 06:30 PM Abstract 13-014 - Severe, Persistent Methotrexate-Related Neurotoxicity in Pediatric Patients with ALL
05:30 PM - 06:30 PM Abstract 13-015 - Intravascular Lymphoma of the Central Nervous System: A Case Series Describing Clinical and Radiographic Characteristics
Megan Richie, MD
05:30 PM - 06:30 PM Abstract 5-001 - Baseline Near Point of Convergence and Concussion Test Scores in a Cohort of Collegiate and Professional Athletes
Nicholas Moehringer
05:30 PM - 06:30 PM Abstract 5-002 - The SUN Test of Vision: Investigation in Healthy Volunteers and Comparison to the Mobile Universal Lexicon Evaluation System (MULES)
Shirley Z. Wu
05:30 PM - 06:30 PM Abstract 5-003 - Analysis of Rapid Sideline Tests and Mechanism of Injury From a Multidisciplinary Concussion Center Registry
Christopher Hernandez, MD
05:30 PM - 06:30 PM Abstract 5-004 - Visual snow syndrome - a clinical and phenotypical description of over 1000 cases
Francesca Puledda
05:30 PM - 06:30 PM Abstract 5-005 - Visual Search for Complex Objects in Healthy Subjects and Individuals with Developmental Prosopagnosia
05:30 PM - 06:30 PM Abstract 5-006 - Cerebral blindness resulting from bilateral optic radiation infarction; a case report
Andrew Dugue, MD
05:30 PM - 06:30 PM Abstract 5-007 - Reversal of vision metamorphopsia (upside-down vision)
Joshua Yap, MBBCh
05:30 PM - 06:30 PM Abstract 5-008 - Anisocoria? No Sweat! A Case Series of Anticholinergic Mydriasis
05:30 PM - 06:30 PM Abstract 5-009 - A Rare Case of Transient Horner Syndrome After Rotator Cuff Repair Surgery
Ruiqing Sun, MD, PhD
05:30 PM - 06:30 PM Abstract 5-010 - B-Mode Ultrasound: a novel tool for evaluation of pupillary function - in healthy and in pathological conditions
Felix Schmidt
05:30 PM - 06:30 PM Abstract 5-011 - Assessing Illness Perception Factors Associated with 好色先生al Needs in Neuro-Ophthalmology
Rem Aziz
05:30 PM - 06:30 PM Abstract 5-012 - Evaluating the Incidence and Neuro-Ophthalmic Manifestations of Carotid-Cavernous Fistulas
Devon Cohen, MD
05:30 PM - 06:30 PM Abstract 5-013 - Ocular Myasthenia Gravis – How Effective is Low Dose Prednisone Long Term?
Rashmi Verma, MD
Faculty Disclosures
Namita Goyal, MD, FAAN Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Souffle. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL Behring. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Goyal has received research support from Fulcrum. The institution of Dr. Goyal has received research support from Healey Platform. The institution of Dr. Goyal has received research support from Medicinova. The institution of Dr. Goyal has received research support from Transposon. The institution of Dr. Goyal has received research support from Abcuro. The institution of Dr. Goyal has received research support from Calico. The institution of Dr. Goyal has received research support from Clene. The institution of Dr. Goyal has received research support from Janssen. The institution of Dr. Goyal has received research support from PepGen. The institution of Dr. Goyal has received research support from PTC. The institution of Dr. Goyal has received research support from Roche. The institution of Dr. Goyal has received research support from Sanofi. The institution of Dr. Goyal has received research support from Prilenia. The institution of Dr. Goyal has received research support from RAPA. The institution of Dr. Goyal has received research support from Avidity. Dr. Goyal has received publishing royalties from a publication relating to health care.
Jeffrey L. Saver, MD, FAAN Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovus. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingelheim (prevention only). Dr. Saver has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Medical Association. Dr. Saver has received stock or an ownership interest from Rapid Medical.
Anette E. Schrag, MD Dr. Schrag has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Otsuka. Dr. Schrag has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merz. Dr. Schrag has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer ingelheim. Dr. Schrag has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bial. The institution of Dr. Schrag has received research support from NIHR, EU, Parkinson's UK, MDS.
Jeff Guptill, MD, FAAN Dr. Guptill has received personal compensation for serving as an employee of argenx. Dr. Guptill has or had stock in argenx.
Peter Goadsby, MD, PhD, FRS Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CoolTech LLC. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health LLC. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kallyope. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seaport Therapeutics. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dr Reddy's. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orion Pharma. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Massachusetts Medical Society. The institution of Dr. Goadsby has received research support from NIHR. Dr. Goadsby has received publishing royalties from a publication relating to health care. Dr. Goadsby has received publishing royalties from a publication relating to health care. Dr. Goadsby has a non-compensated relationship as a Trustee with Migraine Trust that is relevant to AAN interests or activities. Dr. Goadsby has a non-compensated relationship as a Trustee with Organisation for Understanding Cluster Headache (UK) that is relevant to AAN interests or activities.
Scott D. Newsome, DO, FAAN Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Newsome has received research support from Biogen. The institution of Dr. Newsome has received research support from Genentech/Roche. The institution of Dr. Newsome has received research support from Department of Defense. The institution of Dr. Newsome has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Newsome has received research support from National MS Society. The institution of Dr. Newsome has received research support from Lundbeck. The institution of Dr. Newsome has received research support from Sanofi. The institution of Dr. Newsome has received research support from Kyverna Therapeutics. Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving as a Lead PI for Clinical Trial with Roche.
Thomas J. Montine, MD, PhD Dr. Montine has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Enable Medicine. Dr. Montine has stock in Enable Medicine. The institution of Dr. Montine has received research support from NIH. The institution of Dr. Montine has received research support from MJFF. Dr. Montine has received intellectual property interests from a discovery or technology relating to health care. Dr. Montine has received publishing royalties from a publication relating to health care.
Jason Barton, MD, PhD, FRCPC The institution of Dr. Barton has received research support from Canada research Chair. Dr. Barton has received publishing royalties from a publication relating to health care. Dr. Barton has received personal compensation in the range of $500-$4,999 for serving as a guideline for vision therapy in MTBI with ICBC.
Nathalie Jette, MD, MSc, FRCPC, FAAN Dr. Jette has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ILAE Epilepsia. The institution of Dr. Jette has received research support from NIH. The institution of Dr. Jette has received research support from AES.
Gregory L. Barkley, MD No disclosure on file
Veronica E. Santini, MD, MA, FAAN Dr. Santini has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scion NeuroStim, Inc. The institution of Dr. Santini has received research support from MeiraGTx, LLC. The institution of Dr. Santini has received research support from Ono Pharmaceuticals. The institution of Dr. Santini has received research support from Lundbeck. The institution of Dr. Santini has received research support from American Parkinson Disease Association. The institution of Dr. Santini has received research support from Mission MSA. The institution of Dr. Santini has received research support from CurePSP. The institution of Dr. Santini has received research support from Parkinson Foundation. Dr. Santini has received personal compensation in the range of $500-$4,999 for serving as a course director and for committee responsibilities with 好色先生. Dr. Santini has received personal compensation in the range of $500-$4,999 for serving as a course director and for committee responsibilities with International Parkinson and Movement Disorders Society. Dr. Santini has received personal compensation in the range of $0-$499 for serving as a invited speaker with Parkinson Study Group. Dr. Santini has received personal compensation in the range of $500-$4,999 for serving as a data safety monitoring board with NIH.
Alexander Merkler, MD Dr. Merkler has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Neurohospitalist. Dr. Merkler has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for n/a.
Suraj Muley, MD, FAAN Dr. Muley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Muley has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Muley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL Behring. Dr. Muley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Muley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst. Dr. Muley has received publishing royalties from a publication relating to health care.
No disclosure on file
Jorg Dietrich, MD, PhD, FAAN Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Pharmaceuticals. Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson. Dr. Dietrich has received publishing royalties from a publication relating to health care.
Sarah F. Wesley, MD, MPH Dr. Wesley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Wesley has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wesley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG therapeutics.
Naveen George, DO Dr. George has nothing to disclose.
Jaime Hatcher-Martin, MD, PhD, FAAN Dr. Hatcher-Martin has received personal compensation for serving as an employee of Synapticure. Dr. Hatcher-Martin has received personal compensation for serving as an employee of HD Genetics. Dr. Hatcher-Martin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Science37. Dr. Hatcher-Martin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine. Dr. Hatcher-Martin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Hatcher-Martin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Hatcher-Martin has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for npc Parkinson's Disease Journal.
Stewart A. Factor, DO, FAAN Dr. Factor has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Factor has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Factor has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. The institution of Dr. Factor has received research support from Biohaven. The institution of Dr. Factor has received research support from Neurocrine. The institution of Dr. Factor has received research support from Supernus. The institution of Dr. Factor has received research support from Sun Pharmaceuticals Advanced Research Company. The institution of Dr. Factor has received research support from Aspen. The institution of Dr. Factor has received research support from RHO. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care.
Robert E. Chen, MD, MBBChir Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz. Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Chen has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International Federation of Clinical Neurophysiology. Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders. The institution of Dr. Chen has received research support from Canadian Institutes of Health Research. The institution of Dr. Chen has received research support from Natural Science and Engineering Research Council of Canada. Dr. Chen has received research support from Parkinson Foundation. The institution of Dr. Chen has received research support from National Organization for Rare Disease. The institution of Dr. Chen has received research support from Abbvie.
Lisena Hasanaj Ms. Hasanaj has nothing to disclose.
Balasubramanian Samivel, MD Dr. Samivel has nothing to disclose.
Maria Gaughan, MBBS Dr. Gaughan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Gaughan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Gaughan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Gaughan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck.
Mallory N. Luckey, MD Dr. Roberts has nothing to disclose.
Bashar Katirji, MD, FAAN Dr. Katirji has nothing to disclose.
Wengui Yu, MD, PhD Dr. Yu has nothing to disclose.
Hans D. Katzberg, MD, FAAN An immediate family member of Dr. Katzberg has received personal compensation for serving as an employee of Alexion. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL Behring. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. Dr. Katzberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos Health. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX.
Morris Levin, MD, FAAN Dr. Levin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus, Upsher Smith, Biohaven, Revance, Percept, Theranica, Allergan, Alder, Currax. Dr. Levin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Levin has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of the Pacific. Dr. Levin has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Attorney . Dr. Levin has received stock or an ownership interest from Percept. Dr. Levin has received publishing royalties from a publication relating to health care.
Mandip S. Dhamoon, MD, MPH Dr. Dhamoon has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Faegre Baker Daniels LLP. Dr. Dhamoon has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Wellstar Health System Inc. Dr. Dhamoon has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Fabiani Cohen & Hall, LLP. Dr. Dhamoon has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Kramer, Dillof, Livingston & Moore. Dr. Dhamoon has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Robins Kaplan. Dr. Dhamoon has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Parker Waichman LLP. Dr. Dhamoon has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Heidell, Pittoni, Murphy & Bach, LLP.
Michelle M. Mielke, PhD Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LabCorp. Dr. Mielke has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens Healthineers. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunbird Bio. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Mielke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novo Nordisk.
Adel Alhazzani, MD, FRCPC, FAAN Dr. Alhazzani has nothing to disclose.
Michael G. Benatar, MBChB, DPhil, FAAN Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arrowhead. Dr. Benatar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Benatar has received personal compensation in the range of $0-$499 for serving as a Consultant for Annexon. Dr. Benatar has received personal compensation in the range of $0-$499 for serving as a Consultant for UniQure. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cartesian. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Benatar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CorEvitas. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Canopy. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alaunos. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prilenia. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Woolsey. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Benatar has received intellectual property interests from a discovery or technology relating to health care.
Shafeeq Ladha, MD Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Ladha has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Ladha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Ladha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Dr. Ladha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurosense. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rapa Therapeutics. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. Ladha has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Genentech. The institution of Dr. Ladha has received research support from Biogen. The institution of Dr. Ladha has received research support from Sanofi. Dr. Ladha has received publishing royalties from a publication relating to health care.
Elisa Canu The institution of Elisa Canu has received research support from Italian Ministry of Health .
Tanuja Chitnis, MD, FAAN Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Biosciences. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche. The institution of Dr. Chitnis has received research support from Tiziana Life Sciences. The institution of Dr. Chitnis has received research support from Bristol-Myers Squibb. The institution of Dr. Chitnis has received research support from Wesley Clover.
Richard S. Isaacson, MD, FAAN Dr. Isaacson has stock in Retain Health. The institution of Dr. Isaacson has received research support from National Institutes of Health. The institution of Dr. Isaacson has received research support from Aces for Alzheimer's. The institution of Dr. Isaacson has received research support from BrainMind. Dr. Isaacson has received publishing royalties from a publication relating to health care.
Abhishek Lunagariya, MD No disclosure on file
Richard B. Lipton, MD, FAAN Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Roy E. Strowd III, MD, FAAN Dr. Strowd has received personal compensation for serving as an employee of Kaplan. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical, Inc. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. The institution of Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SpringWorks . Dr. Strowd has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. The institution of Dr. Strowd has received research support from Southeastern Brain Tumor Foundation. The institution of Dr. Strowd has received research support from Jazz Pharmaceuticals. The institution of Dr. Strowd has received research support from National Institutes of Health. The institution of Dr. Strowd has received research support from Alpha Omega Alpha. The institution of Dr. Strowd has received research support from American Board of Psychiatry and Neurology. Dr. Strowd has received publishing royalties from a publication relating to health care. Dr. Strowd has received publishing royalties from a publication relating to health care.
Deborah Reed, MD No disclosure on file
Ruth Dobson The institution of Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. The institution of Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . The institution of Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Ruth Dobson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. The institution of Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis . Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sandoz. Ruth Dobson has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Epionex. The institution of Ruth Dobson has received research support from NMSS. The institution of Ruth Dobson has received research support from MS Society UK . The institution of Ruth Dobson has received research support from BMA Foundation . The institution of Ruth Dobson has received research support from Biogen . The institution of Ruth Dobson has received research support from Merck . The institution of Ruth Dobson has received research support from Horne Family Charitable Trust . The institution of Ruth Dobson has received research support from MRC. The institution of Ruth Dobson has received research support from NIHR. Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Medscape . Ruth Dobson has received personal compensation in the range of $0-$499 for serving as a Speaker with Limbus. Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Neurology Academy .
Michael A. De Georgia, MD Dr. De Georgia has nothing to disclose.
Vinaykumar Puduvalli, MD Dr. Puduvalli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Insightec . Dr. Puduvalli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novocure. Dr. Puduvalli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. An immediate family member of Dr. Puduvalli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Newave . Dr. Puduvalli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. Dr. Puduvalli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Insightec, Novocure, Bayer, Servier, . An immediate family member of Dr. Puduvalli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Newave . Dr. Puduvalli has stock in Gilead. Dr. Puduvalli has stock in Moderna. The institution of Dr. Puduvalli has received research support from Merck, Servier, Bexion, Karyopharm, Samus therapeutics.
Erik L. Ortega, MD Dr. Ortega has nothing to disclose.
Haris Kamal, MD Dr. Kamal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Microvention .
Alexandra M. Miller, MD Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Modifi Biosciences.
Kye Won Park, MD Dr. Park has nothing to disclose.
Heather Moss, MD, PhD, FAAN Dr. Moss has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Verana Health. Dr. Moss has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal Firms. The institution of Dr. Moss has received research support from NIH. The institution of Dr. Moss has received research support from Research to Prevent Blindness. Dr. Moss has received intellectual property interests from a discovery or technology relating to health care. Dr. Moss has received personal compensation in the range of $0-$499 for serving as a grant review panel with National Institutes of Health. Dr. Moss has a non-compensated relationship as a Board of Directors with North American Neuro-ophthalmology Society that is relevant to AAN interests or activities.
Ryuji Kaji, MD, FAAN Dr. Kaji has nothing to disclose.
William T. Dauer, MD No disclosure on file
Sandeep S. Rana, MD, FAAN Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSI. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pharmawrite. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amylyx. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Karlo J. Lizarraga, MD, MS, FAAN Dr. Lizarraga has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for FHC. The institution of Dr. Lizarraga has received research support from BlueRock. The institution of Dr. Lizarraga has received research support from Roche. The institution of Dr. Lizarraga has received research support from NIH/NINDS. Dr. Lizarraga has received personal compensation in the range of $500-$4,999 for serving as a Speaker with International Parkinson and Movement Disorders Society. Dr. Lizarraga has received personal compensation in the range of $0-$499 for serving as a Reviewer with National Institutes of Health. Dr. Lizarraga has a non-compensated relationship as a Editorial Board Member for Brain & Life with 好色先生 that is relevant to AAN interests or activities.
Charles Esenwa, MD Dr. Esenwa has nothing to disclose.
Jeff Rodgers Jeff Rodgers has nothing to disclose.
Richard J. Barohn, MD, FAAN Dr. Barohn has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for NuFactor. The institution of Dr. Barohn has received research support from FDA OPD R01. Dr. Barohn has received intellectual property interests from a discovery or technology relating to health care.
Shuichi Suzuki, MD, PhD No disclosure on file
Duaa Jabari, MD Dr. Jabari has nothing to disclose.
Alissa E. Romano, DO Dr. Romano has nothing to disclose.
Ava L. Liberman, MD Dr. Liberman has nothing to disclose.
Seung-Han Lee, MD, PhD Dr. Lee has nothing to disclose.
Michael F. Waters, MD, PhD, FAAN Dr. Waters has nothing to disclose.
Hee-Joon Bae, MD No disclosure on file
Sumit Verma, MD Dr. Verma has nothing to disclose.
John Liang, MD Dr. Liang has nothing to disclose.
Stuart J. McCarter, MD The institution of Dr. McCarter has received research support from NIH. The institution of Dr. McCarter has received research support from American Academy of Sleep Medicine Foundation.
Joontae Kim, MD, PhD Dr. KIM has nothing to disclose.
Tahseen Mozaffar, MD, FAAN Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amicus. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astellas Gene Therapy. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bayer. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics. The institution of Dr. Mozaffar has received research support from NIH. The institution of Dr. Mozaffar has received research support from Muscular Dystrophy Association. The institution of Dr. Mozaffar has received research support from Sanofi. The institution of Dr. Mozaffar has received research support from Argenx. The institution of Dr. Mozaffar has received research support from Amicus Therapeutics. The institution of Dr. Mozaffar has received research support from Astellas Gene Therpay. The institution of Dr. Mozaffar has received research support from Cartesian. The institution of Dr. Mozaffar has received research support from Cabaletta. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH.
Neha Dangayach, MD, FAAN Dr. Dangayach has nothing to disclose.
Jan Drappatz, MD Dr. Drappatz has stock in Pfizer. Dr. Drappatz has stock in Vertex. Dr. Drappatz has stock in GSK. The institution of Dr. Drappatz has received research support from Servier. Dr. Drappatz has received publishing royalties from a publication relating to health care.
Maria Petracca, PhD Dr. Petracca has nothing to disclose.
Philip Van Damme The institution of Dr. Van Damme has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for QurAlis. The institution of Dr. Van Damme has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Van Damme has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for VectorY. The institution of Dr. Van Damme has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NRG Therapeutics. The institution of Dr. Van Damme has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Van Damme has received research support from CSL Behring.
Nicholas Moehringer Mr. Moehringer has nothing to disclose.
Manisha Kak Korb, MD Dr. Kak Korb has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Kak Korb has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Dr. Kak Korb has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Kak Korb has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen.
James F. Howard, Jr., MD, FAAN Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx . Dr. Howard has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron Pharmaceuticals. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Howard has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN (Horizon Therapeutics). Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven Ltd. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CorEvitas. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck EMD Serono. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian Therapeutics. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NMD Pharma. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for H. Lundbeck A/S. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Seismic Therapeutics. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vor Biopharma. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Academic CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PeerView CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Platform Q CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for MJH LifeSci. Dr. Howard has or had stock in Johnson & Johnson dividends.Dr. Howard has or had stock in Pfizer dividends. An immediate family member of Dr. Howard has or had stock in GlaxoSmithKline dividends.Dr. Howard has or had stock in Bristol Myer Squbb dividends.Dr. Howard has or had stock in AbbieVie Inc. The institution of Dr. Howard has received research support from Alexion Pharmaceuticals. The institution of Dr. Howard has received research support from argenx . The institution of Dr. Howard has received research support from UCB Biosciences. The institution of Dr. Howard has received research support from NIH. The institution of Dr. Howard has received research support from Centers for Disease Control/Research Triangle Institute. The institution of Dr. Howard has received research support from Cartestian Therapeutics. The institution of Dr. Howard has received research support from NMD Pharma. The institution of Dr. Howard has received research support from Ad Scientiam. The institution of Dr. Howard has received research support from Merck EMD Serono. Dr. Howard has a non-compensated relationship as a Scientific Advisiory Board member, Committee member with Myasthenia Gravis Foundation of America that is relevant to AAN interests or activities. Dr. Howard has a non-compensated relationship as a Committee member with American Assoc Neuromuscular and Electrodiagnostic Medicine that is relevant to AAN interests or activities.
Kaitlin Reilly-Kit, MD Dr. Reilly-Kit has nothing to disclose.
Andrew Breithaupt, MD The institution of Dr. Breithaupt has received research support from AAN (Research Training Scholarship). The institution of Dr. Breithaupt has received research support from National Institute on Aging. Dr. Breithaupt has received intellectual property interests from a discovery or technology relating to health care. Dr. Breithaupt has received personal compensation in the range of $500-$4,999 for serving as a Consultant (labeling data) with University of California Berkeley.
Leila Darki, MD, FAAN Dr. Darki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Trinity Partner. Dr. Darki has received personal compensation in the range of $0-$499 for serving as a Consultant for Guide point Global. Dr. Darki has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Global Access Meetings. Dr. Darki has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx . Dr. Darki has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amylyx.
Heidi B. Schwarz, MD, FAAN Dr. Schwarz has received personal compensation for serving as an employee of University of Rochester Medical Center. Dr. Schwarz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EBSCO. Dr. Schwarz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepost. Dr. Schwarz has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Various Law Firms.
Jan Verschuuren, MD, PhD The institution of Dr. Verschuuren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. The institution of Dr. Verschuuren has received personal compensation in the range of $0-$499 for serving as a Consultant for Rapharma. Dr. Verschuuren has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Verschuuren has received research support from Argenx.
Scott Janis, PhD No disclosure on file
Frank Lieberman, MD The institution of Dr. Lieberman has received research support from Novocure. The institution of Dr. Lieberman has received research support from Black Diamond. The institution of Dr. Lieberman has received research support from Chimerix. The institution of Dr. Lieberman has received research support from Abbvie.
Nina Y. Riggins, MD, FAAN Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Gerson Lehrman Group . Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KLJ. Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. The institution of Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. The institution of Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal Pharmaceuticals. Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NeurologyLive, MJH Life Sciences. Dr. Riggins has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SpringerNature. The institution of Dr. Riggins has received research support from ElectroCore (GammaCore). The institution of Dr. Riggins has received research support from Miles for Migraine. The institution of Dr. Riggins has received research support from Eli Lilly. Dr. Riggins has received publishing royalties from a publication relating to health care. Dr. Riggins has received publishing royalties from a publication relating to health care. Dr. Riggins has received publishing royalties from a publication relating to health care. Dr. Riggins has a non-compensated relationship as a PI on research study with TheraSpecs that is relevant to AAN interests or activities. Dr. Riggins has a non-compensated relationship as a Advisory Board with NeurologyLive that is relevant to AAN interests or activities. Dr. Riggins has a non-compensated relationship as a Member of the Board with Miles for Migraine that is relevant to AAN interests or activities. Dr. Riggins has a non-compensated relationship as a PI in the study which used sphenocath device with Dolor Technologies that is relevant to AAN interests or activities. Dr. Riggins has a non-compensated relationship as a PI with Theranica that is relevant to AAN interests or activities.
Yasar A. Torres-Yaghi, MD Dr. Torres-Yaghi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Torres-Yaghi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Torres-Yaghi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Torres-Yaghi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbott. Dr. Torres-Yaghi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Torres-Yaghi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Torres-Yaghi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sunovion .
Muniza Sheikh Ms. Sheikh has received personal compensation for serving as an employee of The Emmes Company.
Mary Kay Koenig, MD Dr. Koenig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Marinus Pharmaceuticals. Dr. Koenig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Koenig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stealth BioTherapeutics. Dr. Koenig has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reneo Pharmaceuticals. Dr. Koenig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals. Dr. Koenig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Koenig has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. The institution of Dr. Koenig has received research support from Abliva AB. The institution of Dr. Koenig has received research support from EryDel SPA. The institution of Dr. Koenig has received research support from PTC Therapeutics. The institution of Dr. Koenig has received research support from Noema Pharmaceuticals. The institution of Dr. Koenig has received research support from Marinus Pharmaceuticals. The institution of Dr. Koenig has received research support from Jazz Pharmaceuticals. The institution of Dr. Koenig has received research support from Nflexion Therapeutics. The institution of Dr. Koenig has received research support from Stealth BioTherapeutics. The institution of Dr. Koenig has received research support from Astellas Pharmaceuticals. The institution of Dr. Koenig has received research support from Reneo Pharmaceuticals.
Robert S. Hamilton, MD No disclosure on file
Amanda W. Fletcher, MD Dr. Fletcher has nothing to disclose.
Daniel Belete, MBChB No disclosure on file
Mohammed Alqahtani, MBBS No disclosure on file
Ghazal Ahmad, MD Dr. Ahmad has nothing to disclose.
Camilo R. Gomez, MD, FAAN Dr. Gomez has nothing to disclose.
Staley A. Brod, MD Dr. Brod has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Brod has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi.
Sun Ju Chung, MD, PhD, FAAN Dr. Chung has nothing to disclose.
Sophia Sundararajan, MD Dr. Sundararajan has stock in Boston Scientific Corp. Dr. Sundararajan has stock in Cisco Systems. Dr. Sundararajan has stock in Coca Cola Co. Dr. Sundararajan has stock in Cummins Inc. Dr. Sundararajan has stock in Hartford Insurance group. Dr. Sundararajan has stock in Johnson and Johnson. Dr. Sundararajan has stock in Merck and Company Inc. Dr. Sundararajan has stock in Microsoft. Dr. Sundararajan has stock in Netflix. Dr. Sundararajan has stock in Novartis. Dr. Sundararajan has stock in Oracle Corp. Dr. Sundararajan has stock in Pepsico. Dr. Sundararajan has stock in Proctor and Gamble. Dr. Sundararajan has stock in Qualcomm Inc. Dr. Sundararajan has stock in Travelers Cos Inc. Dr. Sundararajan has stock in Vertex Pharmacueticals. Dr. Sundararajan has stock in Visa Inc. Dr. Sundararajan has stock in Wallmart. Dr. Sundararajan has stock in Zoetis Inc Cl A. The institution of Dr. Sundararajan has received research support from NIH. The institution of Dr. Sundararajan has received research support from AHA.
Melissa Russo No disclosure on file
Goran Rakocevic, MD, FAAN Dr. Rakocevic has nothing to disclose.
Kameshwar Prasad, MD The institution of Prof. Prasad has received research support from Government of India Departments of Health Research and Biotechnology.
Mia T. Minen, MD, FAAN The institution of Dr. Minen has received research support from NIH. Dr. Minen has received intellectual property interests from a discovery or technology relating to health care. Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a First Contact-Primary Care Advisory Board Member with American Headache Society . Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PCORI grant on migraine evidence based map for stakeholders with ECRI .
Natalia Murinova, MD, FAAN Dr. Murinova has nothing to disclose.
Janice M. Massey, MD, FAAN Dr. Massey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenix. Dr. Massey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance Therapeutics. Dr. Massey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Momenta. The institution of Dr. Massey has received research support from Revance .
Don B. Smith, MD, FAAN Dr. Smith has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for 好色先生.
Timothy J. Young, MD, FAAN Dr. Young has nothing to disclose.
Hisatomo Kowa, MD, PhD No disclosure on file
Varun V. Reddy, MD No disclosure on file
Kelly Baldwin, MD Dr. Baldwin has nothing to disclose.
Mehmood Rashid, MD Dr. Rashid has nothing to disclose.
Uzma Usman, MD, FAAN Dr. Usman has nothing to disclose.
Yvo A. Rodriguez-Linares, MD Dr. Rodriguez-Linares has nothing to disclose.
Noemi Piramide, MSc Noemi Piramide has nothing to disclose.
Cindy Gonzalez No disclosure on file
Joachim M. Baehring, MD, FAAN Dr. Baehring has nothing to disclose.
Na Tosha N. Gatson, MD, PhD, FAAN Dr. Gatson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GT Medical Technologies. Dr. Gatson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Menarini Silicon Biosystems. Dr. Gatson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NuvOx Pharmaceuticals. Dr. Gatson has received publishing royalties from a publication relating to health care. Dr. Gatson has a non-compensated relationship as a Board Member with Society for Equity in Neurosciences (SEQUINS) that is relevant to AAN interests or activities.
Nathanael Lee, MD No disclosure on file
Sara Dawit, MD Dr. Dawit has nothing to disclose.
Natalia T. Mendes, MD Dr. Mendes has nothing to disclose.
Massimo Filippi, MD, FAAN Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Howard L. Weiner, MD Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiziana Life Sciences. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for vTv Therapeutics. Dr. Weiner has stock in vTv Therapeutics. The institution of Dr. Weiner has received research support from National Institute of Health. The institution of Dr. Weiner has received research support from National MS Society. The institution of Dr. Weiner has received research support from Genzyme Corp. The institution of Dr. Weiner has received research support from Genentech, Inc. . The institution of Dr. Weiner has received research support from Verily Life Sciences LLC. The institution of Dr. Weiner has received research support from EMD Serono, Inc..
Lisa Hobson-Webb, MD, FAAN Dr. Hobson-Webb has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Therapeutics. Dr. Hobson-Webb has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion . The institution of Dr. Hobson-Webb has received research support from Abcuro. The institution of Dr. Hobson-Webb has received research support from Avidity. Dr. Hobson-Webb has received personal compensation in the range of $500-$4,999 for serving as a 好色先生al Talk - not speaker bureau with Takeda. Dr. Hobson-Webb has received personal compensation in the range of $500-$4,999 for serving as a 好色先生al Talk - not speaker bureau with CSL Behring.
Yahia M. Lodi, MD, FAAN Dr. Lodi has nothing to disclose.
Nikolaus McFarland, MD, PhD, FAAN Dr. McFarland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sutter Health. Dr. McFarland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ONO Pharmaceuticals. Dr. McFarland has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Ferrer. The institution of Dr. McFarland has received research support from NIH, Michael J. Fox Foundation, Huntington Disease Society for America, CurePSP, and Mission MSA.. Dr. McFarland has received publishing royalties from a publication relating to health care.
Fadar O. Otite, MD Dr. Otite has nothing to disclose.
Zafer Keser, MD Dr. Keser has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier Practice Update.
Shaun O. Smart, MD Dr. Smart has nothing to disclose.
Satoshi Kuwabara Satoshi Kuwabara has nothing to disclose.
Yuishin Izumi, MD, PhD No disclosure on file
Carolina B. Maciel, MD, MSCR, FAAN Dr. Maciel has received research support from American Heart Association. Dr. Maciel has received research support from National Institute of Health.
Jeffrey Statland, MD Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ML Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epic Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Armatus . Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kate Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vita Therapeutics. Dr. Statland has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity . Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum Therapeutics. Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex . The institution of Dr. Statland has received research support from NIH. The institution of Dr. Statland has received research support from FSHD Society. The institution of Dr. Statland has received research support from Friends of FSH Research. The institution of Dr. Statland has received research support from FSHD Canada. The institution of Dr. Statland has received research support from MDA.
Christopher J. Fox, MD No disclosure on file
Guido D. Vazquez II, PhD Dr. Vazquez has nothing to disclose.
Vyas Viswanathan, MD No disclosure on file
Amanda Sandoval Karamian, MD The institution of Dr. Sandoval Karamian has received research support from Pediatric Epilepsy Research Foundation.
William T. Hu, MD, PhD, FAAN Dr. Hu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fujirebio. Dr. Hu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Beckman Coulter. Dr. Hu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apellis Pharmaceuticals. The institution of Dr. Hu has received research support from NIA. The institution of Dr. Hu has received research support from TMCity Foundation. The institution of Dr. Hu has received research support from Atlanta Family Foundation. The institution of Dr. Hu has received research support from Fujirebio Diagnostics.
Constantine Farmakidis, MD, FAAN Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for J&J. Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Muscular Dystrophy Association.
Clinton B. Wright, MD, FAAN An immediate family member of Dr. Wright has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Wright has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Abali Milne Kalil. Dr. Wright has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Wright has received personal compensation in the range of $500-$4,999 for serving as a surveyor with ASTRO.
Mark J. Kupersmith, MD, FAAN Dr. Kupersmith has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal firms. Dr. Kupersmith has stock in SafeTherapeutics m,LLC. The institution of Dr. Kupersmith has received research support from NEI, NYEEI FDN, Shulman Family NAION fund. Dr. Kupersmith has received intellectual property interests from a discovery or technology relating to health care.
Steven Warach, MD, PhD Dr. Warach has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. The institution of Dr. Warach has received research support from State of Texas. Dr. Warach has received publishing royalties from a publication relating to health care.
Claire Riley, MD, FAAN Dr. Riley has received personal compensation for serving as an employee of AstraZeneca. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta Bio. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics.
Simone P. Zehntner No disclosure on file
Carl A. Gold, MD, FAAN Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a CME Course Presenter with Oakstone.
Said R. Beydoun, MD, FAAN Dr. Beydoun has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Beydoun has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alnylam. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for CSL. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Takeda. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Janssen. The institution of Dr. Beydoun has received research support from Abcuro. The institution of Dr. Beydoun has received research support from Sean Healy & AMG Center for ALS. The institution of Dr. Beydoun has received research support from Regeneron. The institution of Dr. Beydoun has received research support from RemeGen. The institution of Dr. Beydoun has received research support from Sanofi. The institution of Dr. Beydoun has received research support from Novartis.
Sylvia Klineova, MD Dr. Klineova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Klineova has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Klineova has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Klineova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Joy R. Esterlitz No disclosure on file
Roberta Magliozzi, PhD Dr. Magliozzi has nothing to disclose.
Eric J. Eross, DO No disclosure on file
Fredrik L. Piehl, MD, PhD Dr. Piehl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Parexel/Chugai. The institution of Dr. Piehl has received research support from UCB. The institution of Dr. Piehl has received research support from Merck KGaA. Dr. Piehl has received personal compensation in the range of $10,000-$49,999 for serving as a member scientific advisory board with Swedish Medical products Agency.
Matilde Inglese, MD, PhD Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI GENZYME. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK-SERONO. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Inglese has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MS Journal.
Alastair J. Noyce, MBBS Dr. Noyce has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for uMed. Dr. Noyce has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Noyce has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Noyce has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Charco NeuroTech. Dr. Noyce has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alchemab. Dr. Noyce has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MDS. Dr. Noyce has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIAL. Dr. Noyce has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Oxford Pharmagenesis. Dr. Noyce has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for AstraZeneca. The institution of Dr. Noyce has received research support from Solvemed. The institution of Dr. Noyce has received research support from Alchemab.
James H. Bower, MD, MSc, FAAN The institution of Dr. Bower has received research support from Abbvie.
Viviane H. Zetola, MD Dr. Zetola has nothing to disclose.
Gary Ho, MD, PhD The institution of Dr. Ho has received research support from American Parkinson Disease Association. The institution of Dr. Ho has received research support from NINDS.
Karly Flemmons No disclosure on file
Sarah R. Ahmad Ms. Ahmad has nothing to disclose.
Yasmin Aziz, MD Dr. Aziz has nothing to disclose.
Alan Fowler Mr. Fowler has nothing to disclose.
Chen Chen, MD No disclosure on file
Annika Ehrlich, DNP, FNP-C, AQH, CNRN Dr. Ehrlich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie Pharmaceuticals. Dr. Ehrlich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pharmamark. Dr. Ehrlich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Focus MedEd. Dr. Ehrlich has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Ehrlich has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Ehrlich has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Ehrlich has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for eNeura. Dr. Ehrlich has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Ehrlich has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Axome Therapeutics. Dr. Ehrlich has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Ehrlich has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of the Pacific. Dr. Ehrlich has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Neurology Advanced Practice Providers. Dr. Ehrlich has a non-compensated relationship as a Board President with Alliance for Headache Disorders Advocacy that is relevant to AAN interests or activities. Dr. Ehrlich has a non-compensated relationship as a Board President with The Headache Alliance that is relevant to AAN interests or activities. Dr. Ehrlich has a non-compensated relationship as a Advanced Practice Provider Board Liaison with American Headache Society that is relevant to AAN interests or activities.
Rod Middleton The institution of Mr. Middleton has received research support from MS Society.
Christopher Hernandez, MD No disclosure on file
Hermelinda Abcede, MD Dr. Abcede has nothing to disclose.
Courtney Wusthoff, MD, FAAN Dr. Wusthoff has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for ICON. Dr. Wusthoff has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Wusthoff has received research support from NIH. Dr. Wusthoff has received publishing royalties from a publication relating to health care.
Natalie T. Cheng, MD No disclosure on file
Jose Danilo B. Diestro, MD Dr. Diestro has nothing to disclose.
Mahsa Khayat-Khoei, MD The institution of Dr. Khayat-Khoei has received research support from The National MS Society of America, for Fellowship Award.
Joseph Dardick No disclosure on file
Christopher P. Kellner, MD Dr. Kellner has stock in METIS Innovative. Dr. Kellner has stock in Precision Recovery. Dr. Kellner has stock in Synchron. Dr. Kellner has stock in Fluid BioMed. Dr. Kellner has stock in Proprio. Dr. Kellner has stock in Von Vascular. Dr. Kellner has stock in E8. Dr. Kellner has stock in Borvo. Dr. Kellner has stock in Phantom Neuro. Dr. Kellner has stock in Radical. Dr. Kellner has stock in Reach Neuro. Dr. Kellner has stock in Aurenar. The institution of Dr. Kellner has received research support from Integra. The institution of Dr. Kellner has received research support from Penumbra. The institution of Dr. Kellner has received research support from Viz.AI. The institution of Dr. Kellner has received research support from ICE Neurosystems. The institution of Dr. Kellner has received research support from Irras. The institution of Dr. Kellner has received research support from Microtransponder. The institution of Dr. Kellner has received research support from Medtronic. The institution of Dr. Kellner has received research support from Longeviti. The institution of Dr. Kellner has received research support from Endostream. The institution of Dr. Kellner has received research support from CVAID.
Marcos C. Lange, MD No disclosure on file
Andrea Albonico Andrea Albonico has nothing to disclose.
Clayton A. Wiley No disclosure on file
Mohammed S. Alharbi, MD No disclosure on file
Steven Frucht, MD Dr. Frucht has nothing to disclose.
Janet C. Rucker, MD Dr. Rucker has nothing to disclose.
Sanjib Sinha, MD No disclosure on file
Takashi Yamamura, MD Dr. Yamamura has nothing to disclose.
Christopher P. Robinson, DO Dr. Robinson has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for law firms.
Omar Jawdat, MD Dr. Jawdat has nothing to disclose.
Maulik Shah, MD Dr. Shah has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for National Football League.
Elan Guterman, MD Dr. Guterman has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Guterman has stock in REMO Health. The institution of Dr. Guterman has received research support from NIH. The institution of Dr. Guterman has received research support from AAN.
Sonia M. Caraballo-Cartagena, MD Dr. Caraballo-Cartagena has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Caraballo-Cartagena has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Caraballo-Cartagena has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Caraballo-Cartagena has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Caraballo-Cartagena has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Caraballo-Cartagena has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Caraballo-Cartagena has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alnylam. Dr. Caraballo-Cartagena has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx.
Mamatha Pasnoor, MD, FAAN Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx BVBA. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceutical. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amgen.
Laura J. Balcer, MD, MSCE, FAAN An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children's Hospital of Philadelphia.
Lakshmi N. Ranganathan, MD, PhD, FAAN Dr. Ranganathan has nothing to disclose.
Steven Galetta, MD, FAAN Dr. Galetta has nothing to disclose.
Raissa Villanueva, MD, FAAN Dr. Villanueva has received personal compensation in the range of $500-$4,999 for serving as a speaker honoraria, consulting for CPT with AAN. Dr. Villanueva has received personal compensation in the range of $5,000-$9,999 for serving as a migraine research grant reviewer with American Headache Society. Dr. Villanueva has a non-compensated relationship as a Practice Management Committee CoChair with American Headache Society that is relevant to AAN interests or activities.
Dennis J. Selkoe, MD, FAAN Dr. Selkoe has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Prothena Biosciences. Dr. Selkoe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EISAI.
Richard S. Nicholas, FRCP Dr. Nicholas has nothing to disclose.
Gavin Giovannoni, MD Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck KGaA. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche-Genentech. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astoria Biologica. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medscape.
Rodolfo Savica, MD, PhD, FAAN The institution of Dr. Savica has received research support from ACADIA Pharmaceuticals, Inc.
Fernando L. Pagan, MD, FAAN Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Adamas. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa Kirin. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for US World Meds. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Adamas. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Parkinsonism and related Disorders. Dr. Pagan has stock in Keiferx. The institution of Dr. Pagan has received research support from US World Meds. The institution of Dr. Pagan has received research support from Novartis.
Simon Hawke No disclosure on file
Tigran Kesayan, MD Dr. Kesayan has nothing to disclose.
Alexandra S. Reynolds, MD Dr. Reynolds has nothing to disclose.
Katelyn E. Gay Ms. Gay has received personal compensation for serving as an employee of The Emmes Company, LLC.
Vera Bril, MD Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Powell Mansfield. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Momenta (now J&J). Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Bril has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Bril has received research support from UCB. The institution of Dr. Bril has received research support from Argenx. The institution of Dr. Bril has received research support from Momenta (now J&J). The institution of Dr. Bril has received research support from Immunovant. The institution of Dr. Bril has received research support from Alexion. The institution of Dr. Bril has received research support from Takeda. The institution of Dr. Bril has received research support from Grifols. The institution of Dr. Bril has received research support from CSL. The institution of Dr. Bril has received research support from Octapharma. The institution of Dr. Bril has received research support from Akcea. The institution of Dr. Bril has received research support from Ionis. The institution of Dr. Bril has received research support from Viela Bio (now Horizon). Dr. Bril has received intellectual property interests from a discovery or technology relating to health care.
Renato Mantegazza, MD Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Mantegazza has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SERB. The institution of Dr. Mantegazza has received research support from Alpine Immune Sciences, Inc.
Daniel P. Kurz, MD An immediate family member of Dr. Kurz has received personal compensation for serving as an employee of Grainger. Dr. Kurz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Foundation for Sarcoidosis Research. An immediate family member of Dr. Kurz has or had stock in Grainger. The institution of Dr. Kurz has received research support from Biogen.
Carolyn Zyloney, MD No disclosure on file
Brian Blankenship, MD Dr. Blankenship has nothing to disclose.
Roy X. Zhang, MD No disclosure on file
Kenneth Griffin, MD No disclosure on file
Samuel Belfer, MD, PhD No disclosure on file
Pierpaolo Turcano, MD Dr. Turcano has nothing to disclose.
Shadi V. Barbu, MD No disclosure on file
Laurie E. Knepper, MD Dr. Knepper has nothing to disclose.
Prompan Mingbunjerdsuk, MD No disclosure on file
John H. Erdman III, MD Mr. Erdman has nothing to disclose.
Ian Cossentino, BS No disclosure on file
Peter Ulrichts Peter Ulrichts has received personal compensation for serving as an employee of argenx. Peter Ulrichts has stock in argenx.
David A. Marks, MD Dr. Marks has nothing to disclose.
Laura K. Stein, MD, MPH The institution of Dr. Stein has received research support from American Heart Association.
Cole D. Stang Mr. Stang has nothing to disclose.
Clare Angeli G. Enriquez, MD No disclosure on file
Abinayaa Purushothaman Ravichandran, MBBS Dr. Purushothaman Ravichandran has nothing to disclose.
Hina Aslam, MD, MBBS No disclosure on file
Rebecca J. Levy, MD Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke. An immediate family member of Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for SRB Hawaii Law LLC. An immediate family member of Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Wisner Baum LLP. The institution of Dr. Levy has received research support from CNCDP-K12. The institution of Dr. Levy has received research support from NINDS.
Mazen M. Dimachkie, MD, FAAN Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Octapharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ArgenX. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Catalyst. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Takeda. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medlink. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Astellas. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dianthus. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for TACT / Treat NMD. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Neurological Society of America, Inc . Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Ig Society, Inc. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abcuro. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon/Immunovant. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for 好色先生 (AAN). Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM). Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Annexon Biosciences. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Candid Therapeutics. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Creyon Bio, Inc.. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig Therapeutics. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB Biopharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceuticals. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fortrea. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kriya Therapeutics. The institution of Dr. Dimachkie has received research support from NIH. The institution of Dr. Dimachkie has received research support from The Myositis Association. The institution of Dr. Dimachkie has received research support from Biosensics. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care.
Andrea S. Synowiec, DO, FAAN Dr. Synowiec has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Amgen. Dr. Synowiec has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly. Dr. Synowiec has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Allergan. Dr. Synowiec has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven.
Thomas Hach Thomas Hach has received personal compensation for serving as an employee of Novartis Pharma AG. Thomas Hach has received stock or an ownership interest from Novartis.
Marc Alain Babi, MD Dr. Babi has nothing to disclose.
Rem Aziz Miss Aziz has nothing to disclose.
Namrata Jayaharan Ms. Jayaharan has nothing to disclose.
Nicholas Nelson, MD No disclosure on file
Julianne Baarbé No disclosure on file
Matthew Maas, MD, FAAN The institution of Dr. Maas has received research support from National Institutes of Health.
Jeff Kraakevik, MD, FAAN Dr. Kraakevik has stock in Multiple companies. The institution of Dr. Kraakevik has received research support from Parkinson Foundation. The institution of Dr. Kraakevik has received research support from Syngeric.
Federica Agosta Federica Agosta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philips. Federica Agosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier INC.
Klemens Ruprecht, MD Dr. Ruprecht has received research support from European Union (821283-2). Dr. Ruprecht has received research support from Merck Serono. Dr. Ruprecht has received research support from Stiftung Charite. Dr. Ruprecht has received research support from Arthur Arnstein Foundation. Dr. Ruprecht has received publishing royalties from a publication relating to health care.
Wayne E. Anderson, DO, FAAN An immediate family member of Dr. Anderson has received personal compensation for serving as an employee of Gilead Sciences. Dr. Anderson has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for occasional claims.
Mangala Gopal, MD Dr. Gopal has nothing to disclose.
Joan Sweeney, MD Dr. Sweeney has nothing to disclose.
Aileen Antonio, MD, FAAN Dr. Antonio has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Cochrane. An immediate family member of Dr. Antonio has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Giamarco, Mullins & Horton PC. The institution of Dr. Antonio has received research support from Saint Mary's Foundation. Dr. Antonio has received research support from 好色先生. Dr. Antonio has received personal compensation in the range of $0-$499 for serving as a Invited Speaker with Michigan State University.
Irine Siraj, MD Dr. Siraj has nothing to disclose.
Katharina M. Busl, MD, MS, FAAN Dr. Busl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Rissman Law. Dr. Busl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Huffman Powell Baley. Dr. Busl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for University Science. Dr. Busl has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SCCM. Dr. Busl has a non-compensated relationship as a Board Member with Art in Medicine that is relevant to AAN interests or activities. Dr. Busl has a non-compensated relationship as a Associate Editor with Critical Care Explorations that is relevant to AAN interests or activities. Dr. Busl has a non-compensated relationship as a Assistant Editor with Neurocritical Care that is relevant to AAN interests or activities.
Daniel L. Labovitz, MD An immediate family member of Dr. Labovitz has received personal compensation for serving as an employee of Herrick Feinstein.
Vladimiro Sinay, MD No disclosure on file
Elena Schmidt, MD Dr. Schmidt has nothing to disclose.
Lee E. Neilson, MD Dr. Neilson has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Hart Wagner LLP. Dr. Neilson has received research support from VA ORD - Clinical Science Research and Development. An immediate family member of Dr. Neilson has received research support from NIH - NINDS.
Johnathan L. McKay, PhD The institution of Dr. McKay has received research support from NIH. The institution of Dr. McKay has received research support from the McCamish Foundation.
Carolina Cuello-Oderiz, MD Dr. Cuello-Oderiz has nothing to disclose.
Harsh Patel, MBBS No disclosure on file
Varun Kumar Pala, MD Dr. Pala has nothing to disclose.
Jo Ann Soliven No disclosure on file
Elizabeth Mayne, MD Dr. Mayne has received research support from NINDS-CNCDP K12.
Christopher C. Glisson, DO, FAAN Dr. Glisson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Glisson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for argenx.
Friedemann Paul Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hoffmann-La Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol-Myers Squibb GmbH & Co. KGaA (BMS. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics GmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Paul has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for F&U Confirm. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb GesmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MICE Service. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for VINDICO medical education. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Beijing Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sandoz Internation GmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Thailand. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche . Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology, Neuroimmunology&Neuroinflammation.
Brian C. Healy The institution of Mr. Healy has received research support from Analysis Group. The institution of Mr. Healy has received research support from Bristol-Myers Squibb. The institution of Mr. Healy has received research support from Verily Life Sciences. The institution of Mr. Healy has received research support from Novartis. The institution of Mr. Healy has received research support from Merck Serono. The institution of Mr. Healy has received research support from Genzyme.
Felix Schmidt No disclosure on file
Amanda Opaskar, MD An immediate family member of Dr. Opaskar has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Avon Lake City Schools.
John Peters, MD Dr. Peters has nothing to disclose.
Kelly Valentini No disclosure on file
Rashmi Verma, MD No disclosure on file
Antonio Guglietta Antonio Guglietta has nothing to disclose.
Maria Rosa Rottoli, MD No disclosure on file
Carolina Barnett Tapia, MD Dr. Barnett Tapia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Barnett Tapia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD pharma. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for argenx. The institution of Dr. Barnett Tapia has received research support from Department of defense. The institution of Dr. Barnett Tapia has received research support from Muscular dystrophy canada. The institution of Dr. Barnett Tapia has received research support from MgNet. The institution of Dr. Barnett Tapia has received research support from NIH. The institution of Dr. Barnett Tapia has received research support from Cartesian. The institution of Dr. Barnett Tapia has received research support from Alexion. Dr. Barnett Tapia has received intellectual property interests from a discovery or technology relating to health care.
Dimitrios Papadopoulos, MD No disclosure on file
Jonathan Howard, MD Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MCE Conferences. Dr. Howard has received publishing royalties from a publication relating to health care. Dr. Howard has received publishing royalties from a publication relating to health care. Dr. Howard has received publishing royalties from a publication relating to health care. Dr. Howard has a non-compensated relationship as a Test writer with ABPN that is relevant to AAN interests or activities.
Rebecca L. Hurst, MD Dr. Hurst has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for The Paul Wilkinson law firm.
Tuan H. Vu, MD Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Dianthus. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARGENX. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen (Horizon). Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VOR. Dr. Vu has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL Behring. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Johnson & Johnson. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Vu has received research support from CSL Behring. The institution of Dr. Vu has received research support from Alexion. The institution of Dr. Vu has received research support from RA Pharma/UCB. The institution of Dr. Vu has received research support from ARGENX. The institution of Dr. Vu has received research support from Horizon/Amgen. The institution of Dr. Vu has received research support from CSL Behring. The institution of Dr. Vu has received research support from Cartesian Therapeutics. The institution of Dr. Vu has received research support from Janssen/Johnson & Johnson. The institution of Dr. Vu has received research support from Immunovant. The institution of Dr. Vu has received research support from Regeneron. The institution of Dr. Vu has received research support from Dianthus. The institution of Dr. Vu has received research support from COUR. The institution of Dr. Vu has received research support from NMD Pharma. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Faculty with AcademicCME. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Faculty with CMEO. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Faculty with PER. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Faculty with MedLive.
Charbel E. Moussa, PhD, MB Dr. Moussa has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for KeifeRX LLC. Dr. Moussa has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sun Pharmaceuticals Research Industry. Dr. Moussa has received stock or an ownership interest from Orphan Therapeutics. The institution of Dr. Moussa has received research support from NIA. The institution of Dr. Moussa has received research support from Sun Pharmaceuticals Research Industry. The institution of Dr. Moussa has received research support from Alzheimer's Association . Dr. Moussa has received intellectual property interests from a discovery or technology relating to health care. Dr. Moussa has received intellectual property interests from a discovery or technology relating to health care. Dr. Moussa has received publishing royalties from a publication relating to health care. Dr. Moussa has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with DG Information Technology. Dr. Moussa has received personal compensation in the range of $0-$499 for serving as a Peer Reviews with National Institutes of Health.
Ankita Ghosh, MD Dr. Ghosh has nothing to disclose.
Victoria A. Cannon, MD No disclosure on file
Joseph T. Duong, MD No disclosure on file
Parul Agarwal Parul Agarwal has nothing to disclose.
Sophia Wu, MD No disclosure on file
Jens Kuhle, MD Dr. Kuhle has nothing to disclose.
Elizabeth Pedowitz, MD No disclosure on file
Henry David, MD Dr. David has nothing to disclose.
Jay Shah, MD Dr. Shah has nothing to disclose.
Gishlaine Alfonso, MD, FAAN Dr. Alfonso has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion .
Lei Liu, MD, PhD Dr. Liu has nothing to disclose.
Michael Pizzi, DO, PhD Dr. Pizzi has nothing to disclose.
David Q. Atkins, MD No disclosure on file
Robert G. Smith, MD, PhD, FAAN Dr. Smith has nothing to disclose.
Shimeng Liu, MD, PhD No disclosure on file
Adriana Carra No disclosure on file
Zhu Zhu, MD, PhD Dr. Zhu has nothing to disclose.
Yigit Karasozen, MD Dr. Karasozen has nothing to disclose.
Duong T. Chu, MD Dr. Chu has nothing to disclose.
Steven Yuen, MD No disclosure on file
Kelvin Luk No disclosure on file
Shirley Z. Wu Miss Wu has nothing to disclose.
Ali A. Habib, MD Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for argenx. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NMD Pharma. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon/ Amgen. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kyverna. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jansen/Johnson & Johnson. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMDSerono/Merck. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH/NINDS. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunis Biomedical. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman-La Roche. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for argenx. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jansen/Joohnson & Johnson. The institution of Dr. Habib has received research support from Alexion. The institution of Dr. Habib has received research support from Horizon/Amgen. The institution of Dr. Habib has received research support from Immunovant. The institution of Dr. Habib has received research support from UCB. The institution of Dr. Habib has received research support from argenx. The institution of Dr. Habib has received research support from CabalettaBio. The institution of Dr. Habib has received research support from Regeneron. The institution of Dr. Habib has received research support from Arcellx. The institution of Dr. Habib has received research support from Novartis. The institution of Dr. Habib has received research support from EMDSerono/Merck. The institution of Dr. Habib has received research support from Cour Pharmaceuticals.
Raghav Govindarajan, MD, FAAN Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT pharma. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MT pharma . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Govindarajan has received research support from Band of Hope . The institution of Dr. Govindarajan has received research support from Alexion. Dr. Govindarajan has received publishing royalties from a publication relating to health care.
Justine K. Chan, MD Dr. Chan has nothing to disclose.
Neil Manering, MD Dr. Manering has nothing to disclose.
Jon Beauchamp No disclosure on file
Chase Labiste No disclosure on file
Brandon Lucke-Wold Mr. Lucke-Wold has nothing to disclose.
Judith D. Steinberg, MD No disclosure on file
Anibal Chertcoff Anibal Chertcoff has nothing to disclose.
Ali Manouchehrinia, PhD Dr. Manouchehrinia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Manouchehrinia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Manouchehrinia has received research support from Karolinska Institutet.
Megan Richie, MD Dr. Richie has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology.
Julius Latorre, MD, FAAN Dr. Latorre has nothing to disclose.
Jan A. Hillert, MD Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Hillert has received research support from Biogen. The institution of Dr. Hillert has received research support from Celgene. The institution of Dr. Hillert has received research support from Merck. The institution of Dr. Hillert has received research support from Novartis. The institution of Dr. Hillert has received research support from Sanofi. The institution of Dr. Hillert has received research support from Roche.
Christopher S. Nance, MD No disclosure on file
Naoko Matsui, MD No disclosure on file
Luis J. Mejico, MD, FAAN No disclosure on file
Giulietta Riboldi, MD The institution of Dr. Riboldi has received research support from Prevail Therapeutics.
Chiara Zecca, MD Prof. Zecca has nothing to disclose.
Michael Hansen, MD No disclosure on file
Christopher McGuigan, MD An immediate family member of Prof. McGuigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. McGuigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. McGuigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Prof. McGuigan has received research support from Novartis.
Claudio Gobbi, MD Dr. Gobbi has nothing to disclose.
Barlas Benkli, MD No disclosure on file
Anna Pace, MD Dr. Pace has received personal compensation in the range of $0-$499 for serving as a Conference speaker with 好色先生.
Mohammad Shafie, MD Dr. Shafie has nothing to disclose.
Helen B. Burks, MD No disclosure on file
Devavrat H. Nene, MBBS, DM No disclosure on file
Robert Joseph C. Sarmiento, MD Dr. Sarmiento has nothing to disclose.
Guilherme Olival No disclosure on file
Zachary N. London, MD, FAAN Dr. London has nothing to disclose.
Calli L. Cook, DNP, FNP-C, DAAN, FAAN Dr. Cook has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Cook has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Cook has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer . Dr. Cook has a non-compensated relationship as a Board Member with Alliance for Patient Access that is relevant to AAN interests or activities.
Ilana M. Ruff, MD Dr. Ruff has nothing to disclose.
Elisabetta Sarasso Elisabetta Sarasso has nothing to disclose.
Shivika Chandra, MD, FAAN The institution of Dr. Chandra has received research support from American Board of Psychiatry and Neurology Faculty Innovation in 好色先生 Award. The institution of Dr. Chandra has received research support from Michael J Fox Foundation.
Harn Shiue, PharmD Dr. Shiue has nothing to disclose.
Kathleen Poston, MD, FAAN Dr. Poston has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Curasen Therapeutics, INC. Dr. Poston has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Amprion, INC. Dr. Poston has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Poston has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders Journal. Dr. Poston has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. Dr. Poston has stock in Curasen Therapeutics, INC. Dr. Poston has stock in Amprion, INC. The institution of Dr. Poston has received research support from NIH. The institution of Dr. Poston has received research support from Michael J Fox Foundation. The institution of Dr. Poston has received research support from Alzheimer's Drug Discovery Foundation . The institution of Dr. Poston has received research support from Lewy Body Dementia Association. Dr. Poston has received intellectual property interests from a discovery or technology relating to health care.
Clarisse Carra-Dalliere No disclosure on file
Ahmed M. Yassin, MD Dr. Yassin has nothing to disclose.
Michael G. Case, MS Mr. Case has received personal compensation for serving as an employee of Eli Lilly and Company. Mr. Case has received stock or an ownership interest from Eli Lilly and Company.
Margaret Adler, MD Dr. Adler has nothing to disclose.
Ahmad A. Shawagfeh, MD No disclosure on file
Kathryn Fitzgerald, PhD Dr. Fitzgerald has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Setpoint Medical. The institution of Dr. Fitzgerald has received research support from NIH. The institution of Dr. Fitzgerald has received research support from National MS Society.
Sara Shapouran, MD Dr. Shapouran has nothing to disclose.
Mitesh Patel, MD Dr. Patel has nothing to disclose.
Patrick Landazuri, MD, FAAN Dr. Landazuri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuropace. Dr. Landazuri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuropace. Dr. Landazuri has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Federal Public Defender - District of Kansas. Dr. Landazuri has received publishing royalties from a publication relating to health care.
Joseph F. Quinn, MD, FAAN Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Retrophin. Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving as a DSMB with Alzheimer's Disease Cooperative Study. Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving as a DSMB with Alzheimer's Therapeutic Research Institute. Dr. Quinn has a non-compensated relationship as a consultant with Cognition Therapeutics that is relevant to AAN interests or activities.
Saud Sadiq, BS, FAAN Ms. Brewi has nothing to disclose.
Pierre Labauge, MD Dr. Labauge has nothing to disclose.
Andrea Hidalgo, MD Dr. Hidalgo has nothing to disclose.
Jose L. Torres, MD Dr. Torres has nothing to disclose.
Ildefonso Rodriguez-Leyva, MD, PhD, FAAN Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Laboratorios Columbia.
Masataka Nakamura Masataka Nakamura has nothing to disclose.
Mark Farrenburg, MD Dr. Farrenburg has received publishing royalties from a publication relating to health care.
Shailaja Gaddam, MD No disclosure on file
Ameer Hassan, DO Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Stryker. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Penumbra. Dr. Hassan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cerenovus. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Viz.ai. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Hassan has received research support from GE Healthcare.
Lonni Schultz, PhD Dr. Schultz has nothing to disclose.
Marion S. Buckwalter, MD, PhD No disclosure on file
Cen Zhang, MD Dr. Zhang has nothing to disclose.
Saqib A. Chaudhry, MD Dr. Chaudhry has nothing to disclose.
Francesca Puledda Ms. Puledda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Ms. Puledda has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA.
Anna Fronda No disclosure on file
Kim En Lee, MBBS, MRCP No disclosure on file
Hamza I. Maqsood, MD Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Muhammad F. Suri, MD Dr. Suri has nothing to disclose.
Sairah Bashir, MD, FAAN Dr. Bashir has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic .
Giulio Disanto, MD, PhD The institution of Dr. Disanto has received research support from Swiss MS Sociery.
Bhavesh Trikamji, MD Dr. Trikamji has nothing to disclose.
Marcus Cimino, MD No disclosure on file
Zachary M. Newcomer, DO Dr. Newcomer has nothing to disclose.
Paul M. Elsbernd, MD Dr. Elsbernd has nothing to disclose.
Glen H. Stevens, DO, PhD, FAAN The institution of Dr. Stevens has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Stevens has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for EBSCO. The institution of Dr. Stevens has received research support from National Cancer Institute.
Ebrima Gibbs, Bsc, BMLSc, MSc Dr. Gibbs has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Promis Neurosciences.
Sreeram Ramagopalan No disclosure on file
Helen Hochstetler, PharmD Helen Hochstetler, PharmD has received personal compensation for serving as an employee of Eli Lilly and Company. Helen Hochstetler, PharmD has received stock or an ownership interest from Eli Lilly and Company.
Richard Libman, MD, FAAN Dr. Libman has nothing to disclose.
Jon Williams, DO, PhD Dr. Williams has nothing to disclose.
Hirofumi Kusaka, MD No disclosure on file
Kaviraja Udupa, MD, PhD No disclosure on file
Charles R. Guttmann Charles R.G. Guttmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sintetica SA. Charles R.G. Guttmann has received stock or an ownership interest from Alnylam. Charles R.G. Guttmann has received stock or an ownership interest from Roche. Charles R.G. Guttmann has received stock or an ownership interest from Novartis. Charles R.G. Guttmann has received stock or an ownership interest from Arrowhead Pharmaceuticals. Charles R.G. Guttmann has received stock or an ownership interest from Protalix. Charles R.G. Guttmann has received stock or an ownership interest from Promethee. Charles R.G. Guttmann has received stock or an ownership interest from GSK. Charles R.G. Guttmann has received stock or an ownership interest from Sangamo. Charles R.G. Guttmann has received stock or an ownership interest from Alcon. Charles R.G. Guttmann has received stock or an ownership interest from Cocrystal Pharma. The institution of Charles R.G. Guttmann has received research support from NIH. The institution of Charles R.G. Guttmann has received research support from McGill University. The institution of Charles R.G. Guttmann has received research support from National Multiple Sclerosis Society. The institution of Charles R.G. Guttmann has received research support from BrightFocus Foundation. The institution of Charles R.G. Guttmann has received research support from National Multiple Sclerosis Society. The institution of Charles R.G. Guttmann has received research support from University of Connecticut Health Center. The institution of Charles R.G. Guttmann has received research support from U.S. Office of Naval Research.
Stephan Eisenschenk, MD Dr. Eisenschenk has nothing to disclose.
Luis A. Chui, MD No disclosure on file
Xavier Ayrignac Xavier Ayrignac has nothing to disclose.
Maria Hella, MD Dr. Hella has nothing to disclose.
Raid M. Kofahi, MD Dr. Kofahi has nothing to disclose.
Dennis W. Dickson, MD Dr. Dickson has nothing to disclose.
Fereshteh N. Behdani, MD No disclosure on file
Christoph J. Schankin, MD The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Grünenthal. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lilly. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Schankin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Schankin has stock in Zynnon.
Nizar Souayah, MD, FAAN Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
Devon Cohen, MD No disclosure on file
Yujie Wang, MD Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Wang has received research support from Genentech. The institution of Dr. Wang has received research support from uniQure. The institution of Dr. Wang has received research support from NIH/NINDS.
Maria J. Bruzzone, MD, FAAN Dr. Bruzzone has nothing to disclose.
Maria E. Jimenez-Capdeville, PhD Dr. Jimenez-Capdeville has nothing to disclose.
Ruiqing Sun, MD, PhD Dr. Sun has nothing to disclose.
M. Tariq Bhatti, MD Dr. Bhatti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Receptos . Dr. Bhatti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH LHON gene therapy study .
Marianna V. Spanaki-Varelas, MD, PhD Dr. Spanaki-Varelas has received personal compensation in the range of $500-$4,999 for serving as a RUC ADVISOR with AAN .
Farhan Siddiq, MD Dr. Siddiq has nothing to disclose.
Vibhangini Wasade, MD No disclosure on file
Daniel Cristancho, MD Dr. Cristancho has nothing to disclose.
Clara Arndtsen No disclosure on file
Marcel Daadi, PhD The institution of Prof. Daadi has received research support from NIH. Prof. Daadi has received intellectual property interests from a discovery or technology relating to health care.
Marian Shahid No disclosure on file
Mohammad Qasaimeh, MD No disclosure on file
Jennifer L. Dobson, MD Dr. Dobson has nothing to disclose.
John Chen John Chen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. John Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. John Chen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB.
Majdi Al Qawasmeh No disclosure on file
Lakshmi P. Digala, MD Dr. Digala has nothing to disclose.
Salma Bashayreh, MD Dr. Bashayreh has nothing to disclose.
Kefah A. Al-Hayk, MD Dr. Al-Hayk has nothing to disclose.
Loulwah Mukharesh, MD Dr. Mukharesh has nothing to disclose.
Arooshi Kumar, MD Dr. Kumar has nothing to disclose.
Patricia Linortner, PhD No disclosure on file
Abdel-Hameed Al-Mistarehi Mr. Al-Mistarehi has nothing to disclose.
Yongyao Kong, MBBS Dr. Kong has nothing to disclose.
Sumayyah Abumurad, MBBS Dr. Abumurad has nothing to disclose.
Philipp Karschnia Philipp Karschnia has nothing to disclose.
Cathy A. Sila, MD, FAAN Dr. Sila has nothing to disclose.
Scott Powers, PhD Scott Powers, PhD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Theranica. The institution of Scott Powers, PhD has received research support from NIH. The institution of Scott Powers, PhD has received research support from PCORI. The institution of Scott Powers, PhD has received research support from Cystic Fibrosis Foundation. Scott Powers, PhD has a non-compensated relationship as a Associate Editor with The Journal HEADACHE that is relevant to AAN interests or activities. Scott Powers, PhD has a non-compensated relationship as a Member Board of Directors with American Headache Society that is relevant to AAN interests or activities.
Seemant Chaturvedi, MD, FAHA, FAAN Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Chaturvedi has received research support from NINDS.
Jerry Lin, BS Mr. Lin has nothing to disclose.
Roberto Gomez, MD Dr. Gomez has nothing to disclose.
Mattia Rosso, MD Dr. Rosso has nothing to disclose.
Mina Youn, MD Dr. Youn has nothing to disclose.
John Herbst, DO Dr. Herbst has nothing to disclose.
Eva Christina Meyer, MD No disclosure on file
Sumeet S. Multani, MD No disclosure on file
Urvish K. Patel Mr. Patel has nothing to disclose.
Reyanna Massaquoi, MD No disclosure on file
Praveen Kumar, MBBS No disclosure on file
Megan C. Kirkland No disclosure on file
Keila Narimatsu, MD No disclosure on file
Joshua Yap, MBBCh Dr. Yap has nothing to disclose.
Erika Leese, PA No disclosure on file
Laura E. Lavette No disclosure on file
Julia Granato Miss Granato has nothing to disclose.
Hans Frykman, MD, PhD, FRCPC Dr. Frykman has received personal compensation for serving as an employee of Neurocode LAB.
Gary Slatko, MD Dr. Slatko has received personal compensation for serving as an employee of Aquestive Therapeutics. Dr. Slatko has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Aquestive Therapeutics.
Smitha Chandran No disclosure on file
Daniel I. Feldman, MD No disclosure on file
Volkan Granit, MD Dr. Granit has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Granit has stock in Biohaven. Dr. Granit has received personal compensation in the range of $10,000-$49,999 for serving as a Faculty Member with University of Miami.
Ayanna Santos, PHARM D No disclosure on file
Aiden Payne, PhD No disclosure on file
Amanda Chamberlain No disclosure on file
Eric J. Goldberg, MD No disclosure on file
Beth Rogers-Baggett No disclosure on file
Sara Leddy, MBBS No disclosure on file
Cyrus P. Zabetian, MD The institution of Dr. Zabetian has received research support from American Parkinson Disease Association. The institution of Dr. Zabetian has received research support from Department of Veterans Affairs. The institution of Dr. Zabetian has received research support from NIH. Dr. Zabetian has a non-compensated relationship as a Member, Scientific Advisory Council with Lewy Body Dementia Association that is relevant to AAN interests or activities.
Khalid I. El-Salem, MD, FAAN Dr. El-Salem has nothing to disclose.
Sara K. Rostanski, MD Dr. Rostanski has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Individual law firms.
Ritika Suri, MD Dr. Suri has nothing to disclose.
Frank Lin, MD No disclosure on file
Hannah C. Machemehl, MD No disclosure on file
Lalitha Battineni, MD Dr. Battineni has nothing to disclose.
Anna Iacoangeli, PhD Dr. Iacoangeli has nothing to disclose.
Li Zhu Li Zhu has received personal compensation for serving as an employee of Biogen.
Andrew Dugue, MD Dr. Dugue has nothing to disclose.
Saad I. Yazdani, MD Dr. Yazdani has nothing to disclose.
Nicole Thomason No disclosure on file
Vern C. Juel, MD, FAAN Dr. Juel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Juel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. The institution of Dr. Juel has received research support from argenx. The institution of Dr. Juel has received research support from Alexion. The institution of Dr. Juel has received research support from Janssen. The institution of Dr. Juel has received research support from NIH Rare Diseases Network.
Lutz Harms No disclosure on file
Lalitha Sivaswamy, MD Dr. Sivaswamy has nothing to disclose.
Kara A. Sands, MD Dr. Sands has nothing to disclose.
Richard A. Lewis, MD No disclosure on file
Connie G. Tang, MD Dr. Tang has nothing to disclose.
Stacy L. Johnson, NP Ms. Johnson has nothing to disclose.
Peter Z. Yan, MD, MS Dr. Yan has nothing to disclose.
Pumanshi Talwar No disclosure on file
Shubham Misra, PhD Dr. Misra has nothing to disclose.
Gaurav Thakur, DO Dr. Thakur has nothing to disclose.
Sai P. Polineni, MD Dr. Polineni has nothing to disclose.
Preeti Malik, MPH No disclosure on file
Leon D. Kaulen, MD Dr. Kaulen has nothing to disclose.
Dhaivat J. Shah No disclosure on file
Francesca M. Cali No disclosure on file
Robert A. Rook Mr. Rook has nothing to disclose.
Ali Eltatawy, MD Dr. Eltatawy has nothing to disclose.